Array BioPharma (ARRY) Q4 2020 Earnings Call Transcript : vi

Array BioPharma (ARRY) Q4 2020 Earnings Call Transcript


Operator
Good evening and welcome to Array Technologies fourth-quarter and full-year 2020 earnings conference call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A. At this time, I'd like to turn the call over to Cody Mueller, investor relations of Array Technologies. Thank you.
You may begin.
Investor Relations
Good evening and thank you for joining us on today's conference call to discuss Array Technologies' fourth-quarter and full-year 2020 results. During this conference call, management will make forward-looking statements based on current expectations and assumptions, which are subject to risks and uncertainties. Actual results could differ materially from our forward-looking statements if any of our key assumptions are incorrect because of other factors discussed in today's earnings press release and the comments made during this conference call or in our latest reports and filings with the Securities and Exchange Commission, each of which can be found on our website, arraytechinc.com. We do not undertake any duty to update any forward-looking statements.

Related Keywords

Phoenix , Arizona , United States , America , Jeff Krantz , Jim Fusaro , Cody Mueller , Nipul Patel , Exchange Commission , Us Energy Information Administration , Array Technology Research Center , Array Biopharma , Array Technologies , Array Technologie , North America , President Biden , Information Administration , பீனிக்ஸ் , அரிசோனா , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கா , ஜெஃப் க்ர்யாஂட்ஸ் , ஜிம் புசரோ , கோடி முல்லர் , நீப்புல் படேல் , பரிமாற்றம் தரகு , வரிசை தொழில்நுட்பம் ஆராய்ச்சி மையம் , வரிசை தொழில்நுட்பங்கள் , வரிசை தொழில்நுட்பம் , வடக்கு அமெரிக்கா , ப்ரெஸிடெஂட் பிடென் ,

© 2025 Vimarsana